Strata Skin Sciences PE Ratio 2012-2025 | SSKN
Current and historical p/e ratio for Strata Skin Sciences (SSKN) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Strata Skin Sciences PE ratio as of April 21, 2026 is 0.00.
| Strata Skin Sciences PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-04-21 | 0.13 | 0.00 | |
| 2025-12-31 | 1.26 | $-1.35 | 0.00 |
| 2025-09-30 | 2.06 | $-2.69 | 0.00 |
| 2025-06-30 | 2.29 | $-2.84 | 0.00 |
| 2025-03-31 | 2.64 | $-2.27 | 0.00 |
| 2024-12-31 | 2.91 | $-2.65 | 0.00 |
| 2024-09-30 | 2.75 | $-2.60 | 0.00 |
| 2024-06-30 | 3.07 | $-2.39 | 0.00 |
| 2024-03-31 | 3.78 | $-3.26 | 0.00 |
| 2023-12-31 | 5.50 | $-3.10 | 0.00 |
| 2023-09-30 | 5.95 | $-2.10 | 0.00 |
| 2023-06-30 | 9.50 | $-2.10 | 0.00 |
| 2023-03-31 | 10.59 | $-1.70 | 0.00 |
| 2022-12-31 | 7.90 | $-1.60 | 0.00 |
| 2022-09-30 | 8.71 | $-1.70 | 0.00 |
| 2022-06-30 | 9.61 | $-1.60 | 0.00 |
| 2022-03-31 | 14.70 | $-0.80 | 0.00 |
| 2021-12-31 | 14.65 | $-0.80 | 0.00 |
| 2021-09-30 | 18.40 | $-0.70 | 0.00 |
| 2021-06-30 | 15.60 | $-0.90 | 0.00 |
| 2021-03-31 | 16.70 | $-1.70 | 0.00 |
| 2020-12-31 | 15.00 | $-1.30 | 0.00 |
| 2020-09-30 | 13.50 | $-1.30 | 0.00 |
| 2020-06-30 | 11.50 | $-1.20 | 0.00 |
| 2020-03-31 | 9.50 | $-1.00 | 0.00 |
| 2019-12-31 | 20.80 | $-1.10 | 0.00 |
| 2019-09-30 | 21.50 | $-0.40 | 0.00 |
| 2019-06-30 | 24.90 | $-0.30 | 0.00 |
| 2019-03-31 | 28.50 | $-0.70 | 0.00 |
| 2018-12-31 | 26.00 | $-1.50 | 0.00 |
| 2018-09-30 | 35.40 | $14.00 | 2.53 |
| 2018-06-30 | 20.50 | $-19.00 | 0.00 |
| 2018-03-31 | 11.70 | $-23.50 | 0.00 |
| 2017-12-31 | 12.30 | $-32.60 | 0.00 |
| 2017-09-30 | 17.70 | $-54.60 | 0.00 |
| 2017-06-30 | 24.30 | $-28.50 | 0.00 |
| 2017-03-31 | 30.25 | $-35.00 | 0.00 |
| 2016-12-31 | 22.00 | $-37.70 | 0.00 |
| 2016-09-30 | 26.50 | $-24.30 | 0.00 |
| 2016-06-30 | 30.50 | $-81.70 | 0.00 |
| 2016-03-31 | 47.25 | $-120.50 | 0.00 |
| 2015-12-31 | 55.50 | $-163.50 | 0.00 |
| 2015-09-30 | 57.00 | $-225.00 | 0.00 |
| 2015-06-30 | 57.50 | $-182.50 | 0.00 |
| 2015-03-31 | 128.50 | $-126.00 | 0.00 |
| 2014-12-31 | 60.00 | $-151.50 | 0.00 |
| 2014-09-30 | 86.00 | $-142.50 | 0.00 |
| 2014-06-30 | 160.60 | $-206.50 | 0.00 |
| 2014-03-31 | 311.50 | $-298.50 | 0.00 |
| 2013-12-31 | 320.00 | $-302.00 | 0.00 |
| 2013-09-30 | 365.00 | $-352.00 | 0.00 |
| 2013-06-30 | 465.00 | $-351.00 | 0.00 |
| 2013-03-31 | 580.00 | $-355.00 | 0.00 |
| 2012-12-31 | 895.00 | $-365.00 | 0.00 |
| 2012-09-30 | 1605.00 | $-355.00 | 0.00 |
| 2012-06-30 | 1630.00 | $-390.00 | 0.00 |
| 2012-03-31 | 2240.00 | $-395.00 | 0.00 |
| 2011-12-31 | 1845.00 | $-400.00 | 0.00 |
| 2011-09-30 | 2215.00 | $-420.00 | 0.00 |
| 2011-06-30 | 1170.00 | $-400.00 | 0.00 |
| 2011-03-31 | 1760.00 | $-405.00 | 0.00 |
| 2010-12-31 | 1675.00 | $-415.00 | 0.00 |
| 2010-09-30 | 3260.00 | $-435.00 | 0.00 |
| 2010-06-30 | 3720.00 | $-465.00 | 0.00 |
| 2010-03-31 | 3710.00 | $-475.00 | 0.00 |
| 2009-12-31 | 5155.00 | $-480.00 | 0.00 |
| 2009-09-30 | 4790.00 | $-470.00 | 0.00 |
| 2009-06-30 | 3895.00 | $-465.00 | 0.00 |
| 2009-03-31 | 2175.00 | $-515.00 | 0.00 |
| 2008-12-31 | 1675.00 | $-540.00 | 0.00 |
| 2008-09-30 | 2610.00 | $-530.00 | 0.00 |
| 2008-06-30 | 3830.00 | $-495.00 | 0.00 |
| 2008-03-31 | 2955.00 | $-450.00 | 0.00 |
| 2007-12-31 | 2255.00 | $-420.00 | 0.00 |
| 2007-09-30 | 2750.00 | $-405.00 | 0.00 |
| 2007-06-30 | 3360.00 | $-425.00 | 0.00 |
| 2007-03-31 | 2575.00 | $-445.00 | 0.00 |
| 2006-12-31 | 3600.00 | $-470.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.001B | $0.031B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |